tenofovir disoproxil film-coated tablet
strides pharma science limited(formerly strides strides house, opp. iimb, - tenofovir disoproxil - film-coated tablet - tenofovir disoproxil fumarate - 300mg/lamivudine - lamivudine and tenofovir disoproxil
emtricitabine/tenofovir disoproxil rowex 200 mg/245 mg film-coated tablets
rowex ltd - emtricitabine; tenofovir disoproxil - film-coated tablet - 200 mg/245 milligram(s) - antivirals for treatment of hiv infections, combinations; tenofovir disoproxil and emtricitabine
emtricitabin/tenofovir disoproxil sandoz 200 mg - 245 mg film-coat. tabl.
sandoz sa-nv - emtricitabine 200 mg; tenofovir disoproxil 245 mg - film-coated tablet - 200 mg - 245 mg - emtricitabine 200 mg; tenofovir disoproxil 245 mg - tenofovir disoproxil and emtricitabine
emtricitabine/tenofovir disoproxil mylan
mylan pharmaceuticals limited - emtricitabine, tenofovir disoproxil maleate - hiv infections - antivirals for systemic use - treatment of hiv-1 infection:emtricitabine/tenofovir disoproxil mylan is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults (see section 5.1).emtricitabine/tenofovir disoproxil mylan is also indicated for the treatment of hiv-1 infected adolescents, with nrti resistance or toxicities precluding the use of first line agents, (see sections 4.2, 4.4 and 5.1).pre-exposure prophylaxis (prep):emtricitabine/tenofovir disoproxil mylan is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults and adolescents at high risk (see sections 4.2, 4.4 and 5.1).
emtricitabine/tenofovir disoproxil krka
krka, d.d., novo mesto - emtricitabine, tenofovir disoproxil succinate - hiv infections - antivirals for systemic use - treatment of hiv-1 infectionemtricitabine/tenofovir disoproxil krka is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults.emtricitabine/tenofovir disoproxil krka is also indicated for the treatment of hiv-1 infected adolescents, with nrti resistance or toxicities precluding the use of first line agents, aged 12 to < 18 years (see section 5.1pre-exposure prophylaxis (prep)emtricitabine/tenofovir disoproxil krka is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk.
tenofovir disoproxil fumarate tablet, film coated
aizant drug research solutions pvt ltd - tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) -
efavirenz/ emtricitabine/ tenofovir disoproxil dextreg tablet, film coated 600mg/200mg/245mg,
pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - efavirenz, emtricitabine, tenofovir disoproxil - film-coated tablet - efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil 245 mg - antivirals for systemic use
tenofovir 245mg tablets
dr reddy's laboratories (uk - tenofovir disoproxil - tablet - 245mg
tenofovir 245mg tablets
accord healthcare ltd - tenofovir disoproxil - tablet - 245mg
tenofovir disoproxil actavis 245 milligram tablets
actavis group ptc ehf - tenofovir disoproxil succinate - tablets - 245 milligram - nucleoside and nucleotide reverse transcriptase inhibitors